NSAIDs Can Be Safely Used with Methotrexate
Most NSAIDs (excluding high-dose aspirin) can be safely used with methotrexate for rheumatoid arthritis and other inflammatory conditions, though caution is warranted in patients with renal impairment or other risk factors.
Evidence Supporting NSAID Use with Methotrexate
The FDA label for methotrexate explicitly states that aspirin, NSAIDs, and/or low-dose steroids may be continued when using methotrexate for rheumatoid arthritis, though it notes the possibility of increased toxicity has not been fully explored 1. This represents official regulatory guidance supporting concurrent use.
Multiple guidelines reinforce this position. The 2017 EULAR recommendations for rheumatoid arthritis management acknowledge NSAIDs as part of standard care alongside methotrexate-based DMARD therapy 2. The 2009 multinational methotrexate recommendations found that methotrexate combined with sulfasalazine and hydroxychloroquine did not increase the risk of withdrawal due to toxicity 3.
Pharmacokinetic Evidence
Recent pharmacokinetic studies demonstrate minimal interaction:
- A 2025 systematic review concluded that NSAIDs have minimal impact on methotrexate pharmacokinetics, with only minor increases in clearance observed in 2 of 10 studies 4
- A 1998 study of aspirin, diclofenac, naproxen, indomethacin, and ibuprofen found no significant changes in methotrexate area under the curve, clearance, distribution volume, or half-life 5
- A 1994 study specifically examining ketoprofen, flurbiprofen, and piroxicam showed no effect on methotrexate disposition and concluded these agents "may be used safely in combination with methotrexate" 6
Clinical Safety Data
A 1993 study comparing aspirin versus other NSAIDs in 34 rheumatoid arthritis patients on methotrexate found no clinical difference in toxicity between aspirin and NSAID groups over 12 months, with similar rates of stomatitis, gastrointestinal symptoms, and hepatic toxicity 7.
Important Caveats and Risk Factors
The British Association of Dermatologists guidelines note that while case reports exist of significant morbidity with naproxen, diclofenac, ibuprofen, and indomethacin, these patients often had confounding factors including other interacting drugs and renal impairment 8.
Exercise caution or avoid NSAIDs in patients with:
- Renal insufficiency (most critical risk factor)
- Methotrexate doses >20 mg/week
- Diabetes mellitus
- Dehydration
- Concurrent use of high-dose aspirin (analgesic doses)
- Elderly patients with declining renal function 4
The FDA label specifically warns that NSAIDs can reduce renal elimination of methotrexate, leading to potential toxicity 1. This mechanism is most relevant when renal function is already compromised.
Specific NSAID Considerations
Safer options based on evidence:
- Ketoprofen, flurbiprofen, piroxicam 6
- Standard-dose NSAIDs in patients with normal renal function 4, 5
Require more caution:
- High-dose aspirin (analgesic doses, not low-dose cardioprotective)
- NSAIDs in elderly patients (measure creatinine clearance, not just serum creatinine) 1
Monitoring Recommendations
When using NSAIDs with methotrexate:
- No additional safety monitoring is required for short-term NSAID use (≤14 days) in patients without risk factors 4
- For chronic concurrent use: Continue standard methotrexate monitoring (CBC, liver function, creatinine every 1-3 months) 3
- In patients with risk factors: Individualize monitoring frequency and consider more frequent renal function assessment 8
Antibiotics to Avoid
While NSAIDs are generally safe, absolutely avoid trimethoprim/sulfamethoxazole (co-trimoxazole) with methotrexate due to risk of severe bone marrow suppression from additive antifolate effects 9, 8, 1.